US Patent Issued to Alexion Pharmaceuticals on Sept. 30 for "Anti-ALK2 antibodies and uses thereof" (Connecticut Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,484, issued on Sept. 30, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Anti-ALK2 antibodies and uses thereof" was invented by Jeffrey William Hunter (Wallingford, Conn.), Julian Chandler (Old Lyme, Conn.), Keith Bouchard (Unionville, Conn.), Andre Marozsan (Killingworth, Conn.), Patricia Bento (Plantsville, Conn.) and Anjli Kukreja (Fairfield, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that bind to activin receptor-like kinase 2 (ALK2) and are useful for treating bone disorders, such as those involving reduced bone mineral density and bone mineralization defects, and promoting bone growth. Also pro...